John R. Painter

454 total citations
8 papers, 340 citations indexed

About

John R. Painter is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Cognitive Neuroscience. According to data from OpenAlex, John R. Painter has authored 8 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 3 papers in Experimental and Cognitive Psychology and 2 papers in Cognitive Neuroscience. Recurrent topics in John R. Painter's work include Treatment of Major Depression (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers) and Musculoskeletal pain and rehabilitation (3 papers). John R. Painter is often cited by papers focused on Treatment of Major Depression (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers) and Musculoskeletal pain and rehabilitation (3 papers). John R. Painter collaborates with scholars based in United States and Egypt. John R. Painter's co-authors include Peter D. Londborg, Vincent Glaudin, Joel L. Seres, Ward T. Smith, Alisabet Clain, George I. Papakostas, Victoria Ameral, Lee Baer, Carrie Brintz and Maurizio Fava and has published in prestigious journals such as American Journal of Psychiatry, Pain and Journal of Affective Disorders.

In The Last Decade

John R. Painter

8 papers receiving 309 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Painter United States 8 179 118 103 80 35 8 340
C. A. L. Moon United Kingdom 8 193 1.1× 128 1.1× 118 1.1× 62 0.8× 25 0.7× 11 279
Cohn Jb United States 9 222 1.2× 124 1.1× 157 1.5× 70 0.9× 27 0.8× 14 367
J. J. López-Ibor Spain 8 138 0.8× 49 0.4× 122 1.2× 37 0.5× 46 1.3× 21 312
Jean‐Marie Vanelle France 13 106 0.6× 62 0.5× 220 2.1× 119 1.5× 103 2.9× 49 501
R T Owen United Kingdom 8 121 0.7× 178 1.5× 210 2.0× 114 1.4× 110 3.1× 9 583
John E. Crowder United States 8 184 1.0× 113 1.0× 142 1.4× 53 0.7× 51 1.5× 14 356
T. Koskinen Finland 8 146 0.8× 73 0.6× 141 1.4× 34 0.4× 19 0.5× 9 302
J P Olié France 8 65 0.4× 27 0.2× 98 1.0× 72 0.9× 32 0.9× 19 301
L. Potter United States 10 101 0.6× 66 0.6× 255 2.5× 56 0.7× 68 1.9× 16 423
Ira Fox United States 8 281 1.6× 189 1.6× 192 1.9× 88 1.1× 63 1.8× 8 443

Countries citing papers authored by John R. Painter

Since Specialization
Citations

This map shows the geographic impact of John R. Painter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Painter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Painter more than expected).

Fields of papers citing papers by John R. Painter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Painter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Painter. The network helps show where John R. Painter may publish in the future.

Co-authorship network of co-authors of John R. Painter

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Painter. A scholar is included among the top collaborators of John R. Painter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Painter. John R. Painter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Papakostas, George I., Alisabet Clain, Victoria Ameral, et al.. (2009). Fluoxetine-clonazepam cotherapy for anxious depression: an exploratory, post-hoc analysis of a randomized, double blind study. International Clinical Psychopharmacology. 25(1). 17–21. 16 indexed citations
2.
Smith, Ward T., Peter D. Londborg, Vincent Glaudin, & John R. Painter. (2002). Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?. Journal of Affective Disorders. 70(3). 251–259. 51 indexed citations
3.
Londborg, Peter D., Ward T. Smith, Vincent Glaudin, & John R. Painter. (2000). Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. Journal of Affective Disorders. 61(1-2). 73–79. 67 indexed citations
4.
Londborg, Peter D., et al.. (1998). Short-Term Augmentation of Fluoxetine With Clonazepam in the Treatment of Depression: A Double-Blind Study. American Journal of Psychiatry. 155(10). 1339–1345. 69 indexed citations
5.
Seres, Joel L., et al.. (1981). Multidisciplinary Treatment of Chronic Pain at the Northwest Pain Center. PsycEXTRA Dataset. 36. 41–65. 8 indexed citations
6.
Painter, John R., et al.. (1980). Assessing benefits of the pain center: Why some patients regress. Pain. 8(1). 101–113. 91 indexed citations
7.
Painter, John R., et al.. (1978). A Therapeutic Milieu for Chronic Pain Patients. Journal of Human Stress. 4(2). 8–12. 12 indexed citations
8.
Painter, John R., et al.. (1974). A conjoint-measurement analysis of human judgment. The Mathematics Enthusiast. 12(1). 50–61. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026